Trials / Completed
CompletedNCT01688050
TRANSFIX Zenith® Transection Clinical Study
TRANSFIX - Zenith® TX2® Low Profile Endovascular Graft for Blunt Thoracic Aortic Injury
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Cook Research Incorporated · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
The TRANSFIX study is a clinical trial approved by US FDA to study the safety and effectiveness of the Zenith® TX2® Low Profile Endovascular Graft for treatment of Blunt Thoracic Aortic Injury.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Zenith® TX2® Low Profile Endovascular Graft | Treatment of Blunt thoracic aortic injuries (BTAIs) |
Timeline
- Start date
- 2013-01-23
- Primary completion
- 2014-06-01
- Completion
- 2019-07-29
- First posted
- 2012-09-19
- Last updated
- 2020-11-18
- Results posted
- 2015-11-18
Locations
21 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT01688050. Inclusion in this directory is not an endorsement.